ReviewFrontiers in immunology2020
Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement.
Registry-linked trialOpen access · goldAbstract readReviewConsensus Statement
In one paragraph
Review in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06286007 (Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control), which is not on this map. Cited by 59 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
10.0field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control
Who cites it
59 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.
- Maternal pertussis immunization and the blunting of routine vaccine effectiveness: a meta-analysis and modeling study.Nature communications · 2024Pooled it
- Review
- Maternal Influenza Vaccine Reduces the Risk of Respiratory Syncytial Virus and Related Respiratory Hospitalizations in Early Infancy: An Epidemiological Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- Cost-Effectiveness of Alternative Immunization Strategies to Protect Infants Against Respiratory Syncytial Virus in Germany: A Decision Modeling Study.Infectious diseases and therapy · 2026Article
- Maternal RSV vaccination generates high-affinity antibodies that efficiently transfer to infants, providing enhanced passive immunity.Nature communications · 2026Article
- Global vaccine development.Nature medicine · 2026Review
- Determinants of Tetanus Toxoid Vaccination Among Women of Reproductive Age in Somaliland: A Cross-Sectional Study.Health science reports · 2026Article
- Coadministered Influenza- and Pertussis-Containing Vaccines in Pregnant Women.JAMA network open · 2026Article
- Incidence and Viral Etiology of Acute Respiratory Infections and Pneumonia among Children Under Two Years: A Birth Cohort Study in Dhaka, Bangladesh.The American journal of tropical medicine and hygiene · 2026Article
- Maternal RSV vaccination to protect infants in Brazil: a model-based cost-effectiveness analysis for incorporation into the National Immunisation Program.Lancet regional health. Americas · 2026Article
- Maternal RSV vaccination: clinical efficacy, safety, and global policy considerations: a systematic review.Journal of pharmaceutical policy and practice · 2026Review
- Analysis of epidemiological characteristics and vaccine effectiveness of pertussis in Linping District, China.Frontiers in public health · 2026Article
- Cost-effectiveness of immunization strategies to protect infants against respiratory syncytial virus in the Netherlands.Human vaccines & immunotherapeutics · 2025Article
- Accurizing the Cause of Stillbirth Reviewed Under Maternal and Perinatal Death Surveillance and Response System Through Minimally Invasive Tissue Sampling: A Case Report.Clinical case reports · 2025Article
- Safety and efficacy of maternal RSV vaccination: a systematic review and meta-analysis.Clinical and experimental vaccine research · 2025Review
- Molecular epidemiology of influenza, respiratory syncytial virus, SARS-CoV-2, other respiratory viruses and bacteria among children 0-2-year-olds in West Bengal: a one-year influenza-like illness surveillance study (2022-2023).Frontiers in epidemiology · 2025Article
- Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies.Frontiers in immunology · 2025Review
- Maternal influenza vaccination during pregnancy and the risk of adverse pregnancy and birth outcomes.Frontiers in pharmacology · 2025Article
- Predictors of maternal pertussis vaccination acceptance among pregnant women in Norway.Human vaccines & immunotherapeutics · 2024Article
- Pertussis vaccines, epidemiology and evolution.Nature reviews. Microbiology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
34 authors at 20 institutions in 17 countries.
Bahaa Abu-RayaDepartment of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Kirsten MaertensFaculty of Medicine and Health Sciences, Centre for the Evaluation of Vaccination, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium.
Kathryn M EdwardsDivision of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, United States.
Saad B OmerDepartment of Internal Medicine (Infectious Diseases), Department of Epidemiology of Microbial Diseases, Yale School of Medicine, Yale School of Public Health, New Haven, CT, United States.
Janet A EnglundDepartment of Pediatrics, Seattle Children's Research Institute, University of Washington, Seattle, WA, United States.
Katie L FlanaganFaculty of Health Sciences, School of Medicine, University of Tasmania, Launceston, TAS, Australia.
Matthew D SnapeOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Gayatri AmirthalingamImmunisation and Countermeasures Division, National Infection Service, Public Health England, London, United Kingdom.
Elke LeuridanFaculty of Medicine and Health Sciences, Centre for the Evaluation of Vaccination, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium.
Pierre Van DammeFaculty of Medicine and Health Sciences, Centre for the Evaluation of Vaccination, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium.
Vana PapaevangelouThird Department of Pediatrics, University Hospital ATTIKON, National and Kapodistrian University of Athens, Athens, Greece.
Odile LaunayUniversité de Paris, Inserm, CIC 1417, F-CRIN I REIVAC, Assistance Publique-Hôpitaux de Paris, Paris, France.
Ron DaganThe Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Magda CampinsPreventive Medicine and Epidemiology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Anna Franca CavaliereDipartimento Scienze della Salute della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario "A. Gemelli" IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy.
Tiziana FruscaDepartment of Medicine and Surgery, Obstetrics and Gynaecology Unit, University of Parma, Parma, Italy.
Sofia GuidiDipartimento Scienze della Salute della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario "A. Gemelli" IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy.
Miguel O'RyanMicrobiology and Mycology Program, Faculty of Medicine, Institute of Biomedical Sciences and Associate Researcher, Millennium Institute of Immunology and Immunotherapy, University of Chile, Santiago, Chile.
Ulrich HeiningerPediatric Infectious Diseases, University of Basel Children's Hospital, Basel, Switzerland.
Tina TanDivision of Pediatric Infectious Diseases, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States.
Ahmed R AlsuwaidiDepartment of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Marco A SafadiDepartment of Pediatrics, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil.
Luz M VilcaUnit of Obstetrics and Gynecology, Buzzi Hospital - ASST Fatebenefratelli Sacco, University of Milan, Milan, Italy.
Nasamon WanlapakornCenter of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Shabir A MadhiDepartment of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Michelle L GilesDepartment of Obstetrics and Gynaecology, Monash University, Melbourne, VIC, Australia.
Roman PrymulaSchool of Medicine Hradec Kralove, Institute of Social Medicine, Charles University Prague, Prague, Czechia.
Shamez LadhaniImmunisation and Countermeasures Division, National Infection Service, Public Health England, London, United Kingdom.
Federico Martinón-TorresTranslational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, University of Santiago, Santiago de Compostela, Spain.
Litjen TanImmunization Action Coalition, St. Paul, MN, United States.
Lessandra MichelinInfectious Diseases and Vaccinology Division, Health Sciences Post Graduation Program, University of Caxias Do Sul, Caxias Do Sul, Brazil.
Giovanni ScambiaDipartimento Scienze della Salute della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario "A. Gemelli" IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy.
Nicola PrincipiUniversità degli Studi di Milano, Milan, Italy.
Susanna EspositoDepartment of Medicine and Surgery, Pediatric Clinic, Pietro Barilla Children's Hospital, University of Parma, Parma, Italy.
University of Antwerp · BEPublic Health England · GBUniversità Cattolica del Sacro Cuore · ITUniversity of Milan · ITBarilla (Italy) · ITBen-Gurion University of the Negev · ILCharles University · CZChulalongkorn University · THComplejo Hospitalario Universitario de Santiago · ESFaculdade de Ciências Médicas da Santa Casa de São Paulo · BRImmunization Action Coalition · USIstituti di Ricovero e Cura a Carattere Scientifico · ITLurie Children's Hospital · USMonash University · AUNational and Kapodistrian University of Athens · GRNational Research Foundation · ZASeattle Children's Hospital · USUnited Arab Emirates University · AEUniversidade de Caxias do Sul · BRUniversité Paris Cité · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immunization during pregnancy has been recommended in an increasing number of countries. The aim of this strategy is to protect pregnant women and infants from severe infectious disease, morbidity and mortality and is currently limited to tetanus, inactivated influenza, and pertussis-containing vaccines. There have been recent advancements in the development of vaccines designed primarily for use in pregnant women (respiratory syncytial virus and group B
Indexed as
ImmunizationClinical Trials as TopicConsensusEthics, MedicalFemaleGlobal HealthHealth Impact AssessmentHealth PrioritiesHumansImmunogenicity, VaccineMaternal ExposurePregnancyPregnancy Complications, InfectiousPrenatal Exposure Delayed EffectsResearchRisk AssessmentVaccinesgroup B Streptococcus vaccinesinfluenzamaternal immunizationpertussispregnant womenrespiratory syncytial virustetanus
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
NCT06286007ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.